Nitric oxide synthase inhibitors enhance plasma levels of corticosterone and ACTH

Acta Physiologica Scandinavica

Volumn 157, Issue 2, 1996, Pages 259-264

  Giordano, M ^a   Vermeulen, M ^a   Trevani, A S ^a   Dran, G ^a   Andonegui, G ^a   Geffner, J R ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

ACTH; Corticosterone; Nitric oxide; Steroidogenesis

Indexed keywords

ARGININE; CORTICOSTERONE; CORTICOTROPIN; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; STEROIDOGENESIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029996528     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.1996.482222000.x     Document Type: Article

References (25)

1. 6-nitro-L-arginine and comparisons to alcohol. Life Sciences 50, 35-40.
2. Arndt, H., Russell, J.B., Kurose, I., Kubes, P. & Granger, D.N. 1993. Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis. Gastroenterology 105, 675-680.
3. Bagdi, G., Calogero, A.E., Murphy, D.L. & Szemeredi, K. 1989. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituirary-adrenocortical axis in conscious rats. Endocrinology 125, 2664-2669.
4. Bowen, D.L. & Fauci, A.S. 1988. Pharmacologic modulation of inflammation: Adrenal corticosteroids. In: J.I. Gallin, I.M. Goldstein and R. Snyderman (ed.) Inflammation, pp. 877-896. Raven Press, New York.
5. Cameron, L.A. & Hinson J.P. 1993. The role of nitric oxide derived from L-arginine in the control of steroidogenesis, and perfusion medium flow rate in the isolated perfused rat adrenal gland. J Endocrinol 139, 415-423.
6. Cook, D.M., Kendall, J.W., Greer, M.A. & Kramer, R.M. 1972. The effect of acute or chronic stress on plasma ACTH concentration in the rat. Endocrinology 93, 1019-1024.
7. Costa, A., Trainer, P., Besser, M. & Grossman, A. 1993. Nitric oxide modulates the release of corticotropin-releasing hormone from rat hypothalamus in vitro. Brain Res 605, 187-192.
8. G-monomethyl-L-arginine (L-NMMA) in conscious rats. In: S. Moncada and E.A. Higgs (eds) Nitric Oxide From L-Arginine: a Bioregulatory System, pp. 489-491. Elsevier, Amsterdam.
9. Grossman, A. 1994. Editorial; NO news is good news. Endocrinol. 134, 1003-1004.
10. Kadowaki, K., Kishimoto, J., Leng, G. & Emson, P.C. 1994. Up-regulation of nitric oxide synthase (NOS) gene expression together with NOS activity in the rat hypothalamo-hypophysial system after chronic salt loading; evidence of a neuromodulatory role of nitric oxide on arginine vasopressin and oxytocin secretion. Endocrinology 134, 1011-1017.
11. Karanth, S., Lyson, K. & McCann, S.M. 1993. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proc Natl Acad Sci USA 90, 3383-3387.
12. Knowles, R.G. & Moncada, S. 1994. Nitric oxide synthases in mammals. Biochem J 298, 249-258.
13. Kubes, P., Suzuki, M. & Granger, D.N. 1991. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88, 4651-4655.
14. Kubes, P. & Granger, D.N. 1992. Nitric oxide modulates microvascular permeability. Am J Physiol 262, H611-H615.
15. Mason, D., MacPhee, I. & Antoni, F. 1990. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology 70, 1-5.
16. Mason, D. 1991. Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunol Today 12, 57-60.
17. McCartney-Francis, N., Allen, J.B., Mizel, D.E., Albina, J.E., Xie, Q., Nathan, C.F. & Wahl, S.M. 1994. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 178, 749-754.
18. Moncada, S. 1992. The L-arginine: nitric oxide pathway. Acta Physiol Scand 145, 201-227.
19. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB 6, 3051-3064.
20. Palacios, M., Knowles, R.G., Palmer, R.M.J. & Moncada, S. 1989. Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands. Biochem Biophys Res Commun 165, 802-809.
21. Rees, D.D., Palmer, R.M.J. & Moncada, S. 1989. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 86, 3375-3378.
22. Rojas, A., Padron, J., Caveda, L., Palacios, M. & Moncada S. 1993. Role of nitric oxide pathway in the protection against lethal endotoxemia afforded by low doses of lypopolysaccharide. Biochem Biophys Res Commun 191, 441-446.
23. Schmidt, H.H.W., Warner, T.D., Ishii, K., Sheng, H. & Murad, F. 1992. Insuline secretion from pancreatic beta cells caused by L-arginine-derived nitrogen oxides. Science 255, 721-723.
24. Shultz, P.J. & Raij, L. 1992. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 90, 1718-1725.
25. G-monomethy L-L-arginine. J Exp Med 179, 651-660.